Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Tumor-Suppressor Genes Turned Off by 3′ UTR Shortening

Page View:

Researchers say they have uncovered new information that more accurately explains how cancerous tumors grow within the body. Their study (“3’ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk”) appears in Nature Genetics. For more details about Medicilon’s tumor model.

The team, led by scientists at The University of Texas Medical Branch (UTMB) at Galveston and Baylor College of Medicine, found that losing a section of mRNA that was previously thought to transform normal cells into cancerous ones actually acts by blocking the body’s ability suppress the formation of tumors. The finding could completely alter the way that medical science approaches the formation of tumors, according to the researchers.

“Widespread mRNA 3′ UTR [3′ untranslated region] shortening through alternative polyadenylation promotes tumor growth in vivo. A prevailing hypothesis is that it induces proto-oncogene expression in cis through escaping microRNA-mediated repression. Here we report a surprising enrichment of 3′ UTR shortening among transcripts that are predicted to act as competing-endogenous RNAs (ceRNAs) for tumor-suppressor genes. Our model-based analysis of the trans effect of 3′ UTR shortening (MAT3UTR) reveals a significant role in altering ceRNA expression. MAT3UTR predicts many trans-targets of 3′  UTR shortening, including PTEN, a crucial tumor-suppressor gene involved in ceRNA crosstalk with nine 3′ UTR-shortening genes, including EPS15 and NFIA,” write the investigators.

“Knockdown of NUDT21, a master 3′ UTR-shortening regulator, represses tumor-suppressor genes such as PHF6 and LARP1 in trans in a miRNA [microRNA]-dependent manner. Together, the results of our analysis suggest a major role of 3′ UTR shortening in repressing tumor-suppressor genes in trans by disrupting ceRNA crosstalk, rather than inducing proto-oncogenes in cis.”

In molecules throughout the body, the 3′ UTR is a section of mRNA that can alter gene expression. It’s known that shortening this RNA section promotes cancerous tumor growth.

“Researchers have historically thought that this was because 3′ UTR shortening induces the expression of proto-oncogenes, normal genes that when altered by mutation or expressed too high, become oncogenes that can transform a normal cell into a cancer cell,” said Eric Wagner, Ph.D., UTMB associate professor in the department of biochemistry and molecular biology. “However, using a combination of computational approaches and cancer cell models, we found that 3′ UTR shortening in tumors actually causes tumor-suppressing genes to be turned off.”

The researchers used big data analyses to reconstruct the RNA thought to form global regulatory networks within breast tumor cells and their matched normal tissues. This approach identified the fact that 3′ UTRs are vital in regulating these global regulatory networks. Using this new information, they then disrupted these networks within breast cancer cells to test the effects on tumor growth.

Relevant newsRelevant news